Gilead Sciences is a large biopharmaceutical company that develops and sells medicines, including treatments for HIV. Its filings show it lobbies on health access and HIV medication issues, and on pharmacy benefit manager (PBM) reform and U.S. global HIV funding through PEPFAR (the President’s Emergency Plan for AIDS Relief).
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
E. BRANDON GARRETT
The latest disclosures for this client.
EMPIRE CONSULTING GROUP
Q2EMPIRE CONSULTING GROUP
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
EMPIRE CONSULTING GROUP
MIKE MCKAY
EMPIRE CONSULTING GROUP
BRIAN GREER
EMPIRE CONSULTING GROUP
MICHAEL HAYES
EMPIRE CONSULTING GROUP
EMPIRE CONSULTING GROUP
Q4EMPIRE CONSULTING GROUP
Q3EMPIRE CONSULTING GROUP
Q2EMPIRE CONSULTING GROUP
Q1